USFDA Flags One Observation at Cipla Plant

  Published 8 months ago

Cipla received one Form 483 observation after a USFDA cGMP inspection held from 26–30 May 2025.

  • Classification was officially communicated to Cipla via email on 4 August 2025 by the USFDA.
  • Cipla assured full cooperation and plans to address the observation comprehensively within the given timeline.
  • The company remains committed to compliance while focusing on growth in key global and emerging markets.

You might like these

PNG Gadgil Q1 FY26: 30.4% Growth, Strategic Expansion

Lumax Auto Tech Shares Rise on Margin Outlook

India PMI Shows Slower Service Growth

City Union Bank Gains on Strong Q1 Show

RBI Extends Financial Market Trading Hours

IRFC Q1 Profit Rises 11% YoY

SJVN Plans ₹12 Cr Capex, Hydro Records

News that matters the most ⚡